| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.90B | +18.5% |
| Cost of Revenue | $619.1M | +31.2% |
| R&D Expense | $525.1M | +13.3% |
| SG&A Expense | $518.5M | -3.2% |
| Operating Income | $589.3M | +38.0% |
| Pre-tax Income | $658.8M | +29.9% |
| Income Tax | $215.5M | +88.6% |
| Net Income | $443.3M | +12.8% |
| EPS (Basic) | $0.91 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $658.2M | -51.9% |
| Short-term Investments | $644.9M | +16.8% |
| Accounts Receivable | $3.77B | +13.2% |
| Current Assets | $5.26B | -1.4% |
| Total Assets | $6.15B | +0.7% |
| Current Liabilities | $3.27B | +13.7% |
| Total Liabilities | $3.67B | +16.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $992.7M | +34.3% |
| Capital Expenditures | $197.0M | +100.5% |
| Investing Cash Flow | -$292.6M | -85.8% |
| Financing Cash Flow | -$1.41B | -1211.6% |
| Free Cash Flow | $795.7M | +24.1% |
| +13.7% |
| EPS (Diluted) | $0.90 | +15.4% |
| Stockholders' Equity |
| $2.48B |
| -15.8% |